Natural Astaxanthin Oil and Powder from Haematococcus Pluvialis Supplier in China
A supplement or functional food project can stall for a simple reason: the active ingredient is available, but not in the right form, strength, or lead time. Astaxanthin is a good example. A softgel line may need oil. A sachet, tablet, or beverage concept may need powder. A cold water blend needs solubility that standard powder cannot provide.
This case study looks at how ACNS001 Natural Astaxanthin Oil and Powder, sourced from Haematococcus pluvialis, helps solve that sourcing problem. The product range is supplied by A Clover Nutrition Inc, an 11-year supplier in China, with multiple HPLC-tested specifications, a 1 kg minimum order quantity, and a typical lead time of 2 to 4 working days.
Background on the ACNS001 astaxanthin range
ACNS001 is a natural astaxanthin ingredient line made from Haematococcus pluvialis, a microalga known for producing astaxanthin under stress conditions. In commercial ingredient sourcing, this source is valued because it supports a natural-positioned astaxanthin product rather than a synthetic alternative.
The ACNS001 range includes oil and powder formats. This is useful for product developers because astaxanthin is commonly used across different dosage forms. One formulation may need a lipid-based ingredient for capsules, while another may need a powder that can be added to dry blends.
The listed CAS number for astaxanthin is 472-61-7. This helps purchasing and technical teams align product records, import documents, and internal ingredient databases.
The available specifications are:
Product option | Specification | Testing method stated |
Natural Astaxanthin Oil | 5.0% | HPLC |
Natural Astaxanthin Oil | 10.0% | HPLC |
Natural Astaxanthin Cold Water Soluble Powder | 2% | HPLC |
Natural Astaxanthin Powder | 5% | HPLC |
Natural Astaxanthin Powder | 3% | HPLC |
The primary supply promise is practical: 2 to 4 working days lead time, 1 kg MOQ, and samples offered based on the requested quantity.
The sourcing problem the buyer needed to solve
In this case, the buyer was not simply looking for an astaxanthin ingredient. The project needed a supplier that could cover several development paths at once.
The formulation team was comparing three possible product formats:
Softgels
Dry powder blends
Cold water drink mixes
Each format placed different demands on the ingredient.
The softgel concept needed an oil-soluble ingredient. The dry blend concept needed a powder that could mix with other actives and excipients. The drink mix concept needed a cold water soluble option to reduce visible particles and improve user experience.
That created four practical sourcing challenges.
The buyer needed more than one concentration
A single concentration can limit formulation work. If the active is too low, the formula may need too much carrier material. If it is too high, dosing and blend uniformity can become harder to manage.
The ACNS001 range gave the buyer a choice between 5.0% and 10.0% oil, plus 2%, 3%, and 5% powder options. That let the technical team compare concentration, dose size, and finished product format before committing to a larger order.
The buyer needed test-backed specifications
For a commercial ingredient, the percentage on the label is not enough. The buyer needed a stated analytical method. ACNS001 specifications are listed with HPLC, a common analytical method used to quantify active compounds in botanical and nutritional ingredients.
This helped the buyer move the conversation from general product availability to technical review.
The buyer needed a low starting quantity
Early-stage formulation does not always need a large order. A large MOQ can force a company to buy more material than it needs before it has confirmed stability, flavour, dosage, or manufacturing compatibility.
The ACNS001 MOQ of 1 kg helped the buyer begin practical trials without taking on unnecessary volume.
The buyer needed speed
Ingredient delays can slow down pilot production. The stated delivery preparation window of 2 to 4 working days gave the buyer a clear planning basis for sample evaluation and small-batch testing.
That short lead time mattered because the formulation team was comparing multiple versions in parallel.
The approach used to qualify the ingredient
A Clover Nutrition Inc positioned ACNS001 as a flexible ingredient range rather than a single standard product. The qualification process focused on matching the correct specification to the intended application.
The buyer reviewed the product in four steps.
Step 1 looked at the source and identity
The first question was whether the ingredient matched the desired source. ACNS001 is described as natural astaxanthin from Haematococcus pluvialis. In internal documents, the buyer recorded it as natural astaxanthin (Haematococcus pluvialis Extract) with CAS 472-61-7.
That identity check helped the team separate the ingredient from synthetic astaxanthin options and from unrelated carotenoid materials.
Step 2 matched oil options to softgel development
For softgels, the buyer compared the two oil specifications:
Oil option | Main use case | Practical benefit |
5.0% HPLC oil | Lower-dose or easier handling trials | More room in the formula for carrier oils |
10.0% HPLC oil | Higher-strength softgel concepts | Less ingredient volume needed for the same astaxanthin input |
The team did not need to choose immediately. Both oil strengths could be assessed based on capsule fill weight, target active level, and processing fit.
This is where Natural astaxanthin oil had the clearest role. It gave the softgel project a direct route to a lipid-based format without forcing the team to disperse a dry powder into oil during early testing.
Step 3 matched powder options to dry blends and tablets
For powders, the buyer looked at three specifications:
Natural Astaxanthin 3% Powder
Natural Astaxanthin 5% Powder
Natural Astaxanthin 2% Cold Water Soluble Powder
The 3% and 5% powders were relevant for dry dosage forms and premixes. The 2% cold water soluble powder was more relevant for beverage-style applications, where dispersion in cold liquid can affect the final user experience.
This gave the buyer a way to test product concepts without changing supplier for every format.
Step 4 requested samples based on development needs
The supplier stated that samples could be offered based on the required quantity. For the buyer, this reduced uncertainty. Instead of ordering a fixed sample size that might not fit the trial plan, the team could request a sample quantity aligned with actual formulation work.
That is especially useful when several forms need side-by-side testing. A powder blend trial may need a different sample amount from a softgel compatibility trial.
The measurable results of the qualification
The outcome was not a vague supplier shortlist. The buyer gained a clear set of ingredient choices and ordering parameters that could be used for real development planning.
Five commercial specification options were identified
The ACNS001 range gave the buyer five defined specifications across oil, powder, and cold water soluble powder.
That mattered because the project did not have to stop at one finished-product idea. The same supplier range could support several prototypes:
Prototype direction | Suitable ACNS001 option |
Softgel supplement | 5.0% or 10.0% natural astaxanthin oil |
Capsule or tablet blend | 3% or 5% natural astaxanthin powder |
Powder sachet | 3% or 5% natural astaxanthin powder |
Cold water drink mix | 2% cold water soluble powder |
The buyer could keep ingredient identity consistent while changing format.
The MOQ stayed at 1 kg
The 1 kg MOQ gave the buyer a practical entry point. This size is especially helpful when the purpose is trial production, stability screening, or product sampling rather than a full commercial launch.
For many formulation projects, the difference between a 1 kg MOQ and a much larger starting order affects speed and budget. Here, the lower starting quantity made it easier to move from document review to hands-on testing.
The lead time supported short development cycles
The stated 2 to 4 working day lead time gave the buyer a clear timeline for planning pilot work.
That does not replace customs clearance, international transport time, or local receiving checks. Still, it gives the project team a defined supplier-side preparation window. In early-stage development, that level of clarity can remove several days of uncertainty.
The supplier had 11 years of supply history
A Clover Nutrition Inc is described as an 11-year supplier in China. For buyers, supplier history does not replace quality checks, but it does add useful context.
A longer operating history can support the qualification discussion because the buyer can ask for standard documents, batch details, sample support, and specification confirmation from a supplier that has experience with ingredient export and customer requirements.
What the case shows about astaxanthin ingredient sourcing
This case shows that astaxanthin sourcing is not only about finding a natural active. It is about matching source, format, strength, test method, and order size to the stage of development.
A buyer evaluating ACNS001 gained three practical advantages.
Format flexibility reduced early sourcing risk
The project did not need separate suppliers for oil, standard powder, and cold water soluble powder. That made comparison easier.
The buyer could assess multiple prototypes while keeping the same source material family. This is useful when the finished product format has not yet been fixed.
Clearly stated strengths made formulation work easier
The listed concentrations helped the technical team calculate trial inputs. A 10.0% oil behaves differently in formulation planning than a 5.0% oil. A 2% cold water soluble powder serves a different purpose from a 5% standard powder.
Clear specifications reduce guesswork at the bench.
Small-order access supported testing before scale-up
The 1 kg MOQ kept the project realistic. The team could test the ingredient in actual formulas before making larger purchasing decisions.
This is a sensible approach for natural ingredients, where colour, carrier system, solubility, and processing fit can all affect the finished product.
Key lessons for other astaxanthin buyers
The ACNS001 case offers several lessons for teams comparing natural astaxanthin ingredients.
Start with the finished product format
Oil and powder are not interchangeable in every formula. A softgel project should begin with oil options. A sachet, tablet, or beverage project should begin with powder suitability and solubility.
Choosing the format first prevents wasted sample testing.
Compare concentration against dose and handling
A higher concentration is not always better. It may reduce ingredient volume, but it may also change handling, dispersion, or dosing requirements.
The practical question is simple: which strength fits the finished product with the least formulation friction?
Ask for the test method early
HPLC-listed specifications give the technical team a clearer basis for review. Buyers should still request current documentation for the batch under consideration, such as specification sheets and relevant quality documents.
Use sample orders to test real conditions
A sample should be tested in the intended formula, not only inspected visually. Colour, odour, solubility, processing temperature, and compatibility with other ingredients can all affect the final decision.
The ACNS001 range makes that process easier because samples can be discussed based on the required quantity.
The takeaway from this supplier case
ACNS001 Natural Astaxanthin Oil and Powder gives buyers a practical route to natural astaxanthin from Haematococcus pluvialis in several usable forms. The range includes 5.0% and 10.0% HPLC oil, 2% cold water soluble powder, and 3% and 5% powder, with CAS 472-61-7 for ingredient identification.
The key result is flexibility. A buyer can test softgels, dry blends, tablets, capsules, and cold water drink concepts without starting from scratch for each format. With a 1 kg MOQ, sample support based on required quantity, and a stated 2 to 4 working day lead time, A Clover Nutrition Inc provides a clear starting point for astaxanthin product development from China.
Comments